在Crizotinib治疗无塑性淋巴瘤激酶阳性淋巴瘤期间成功怀孕
Veronica Guglielmana1,2, Francesco Maria Fusi3, Valentina Giardini4
1Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Hematological oncology
|January 14, 2025
概括
形淋巴瘤激酶阳性形大细胞淋巴瘤 (ALK+ALCL) 患者可以成功怀孕. 四个案例表明,克里佐替尼治疗可以支持怀孕,而不会恶化ALK+ALCL疾病控制.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 生殖医学 生殖医学
背景情况:
- 形淋巴瘤形大细胞淋巴瘤 (ALK+ALCL) 主要影响年轻成年人.
- 虽然细胞毒药物是有效的,但超过50%的患者出现复发.
- 克里佐替尼改善了结果,但对于希望成为父母的患者来说,这引发了担忧.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


